INCY · ISSUER CIK 879169
INCYTE CORP
Between Jul 31, 2026 and Oct 28, 2026, 8 INCYTE CORP insiders reported $0.00 of open-market purchases and $15.0M of sales on SEC Form 4.
↗8 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 8 of 8 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$15.0MInsider selling
−$15.0MNet open-market
Oct 19, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 19, 202616:38 | Oct 15, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $112.71 | −2,642 | 183,200 | -1% | −$298K | ||
| Oct 19, 202616:38 | Oct 15, 2026 | INCY | President, Global Head of R&D | M · Exercise10b5-1 | $65.76 | +2,642 | 185,842 | +1% | $174K | ||
| Oct 5, 202616:01 | Oct 1, 2026 | INCY | EVP, Head of Incyte Intl | F · Tax | $117.14 | −463 | 37,578 | -1% | $54K | ||
| Oct 2, 202617:54 | Sep 30, 2026 | INCY | Director, 10% Owner · +5 joint | A · Grant | — | +644 | 28,206,082 | +0% | — | ||
| Oct 2, 202616:02 | Sep 30, 2026 | INCY | Director | A · Grant10b5-1 | $121.35 | +203 | 25,838 | +1% | $25K | ||
| Oct 2, 202616:02 | Sep 30, 2026 | INCY | Director | A · Grant10b5-1 | $121.35 | +206 | 23,225 | +1% | $25K | ||
| Sep 24, 202616:06 | Sep 22, 2026 | INCY | EVP, Chief Strategy Officer | F · Tax | $126.93 | −920 | 15,904 | -5% | $117K | ||
| Sep 17, 202616:04 | Sep 15, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $120.49 | −23,218 | 183,200 | -11% | −$2.8M | ||
| Sep 17, 202616:04 | Sep 15, 2026 | INCY | President, Global Head of R&D | M · Exercise10b5-1 | $66.39 | +23,218 | 206,418 | +13% | $1.5M | ||
| Aug 27, 202616:07 | Aug 25, 2026 | INCY | EVP, Human Resources | F · Tax | $129.72 | −504 | 10,993 | -4% | $65K | ||
| Aug 20, 202617:15 | Aug 19, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $125.56 | −10,801 | 183,200 | -6% | −$1.4M | ||
| Aug 14, 202616:01 | Aug 12, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $120.04 | −10,803 | 194,001 | -5% | −$1.3M | ||
| Aug 7, 202616:02 | Aug 5, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $122.69 | −10,640 | 204,804 | -5% | −$1.3M | ||
| Aug 7, 202616:01 | Aug 5, 2026 | INCY | EVP & Chief Scientific Officer | S · Sell10b5-1 | $123.99 | −2,207 | 61,441 | -3% | −$274K | ||
| Aug 7, 202616:01 | Aug 5, 2026 | INCY | EVP & Chief Scientific Officer | M · Exercise10b5-1 | $106.47 | +2,207 | 63,648 | +4% | $235K | ||
| Aug 4, 202616:04 | Jul 31, 2026 | INCY | President, Global Head of R&D | S · Sell10b5-1 | $119.70 | −15,888 | 215,444 | -7% | −$1.9M | ||
| Aug 4, 202616:04 | Aug 3, 2026from Jul 31, 2026 | INCY | EVP & Chief Scientific Officer | S · Sell10b5-1 | $119.58 | −47,954 | 61,441 | -44% | −$5.7M | ||
| Aug 4, 202616:04 | Aug 3, 2026from Jul 31, 2026 | INCY | EVP & Chief Scientific Officer | M · Exercise10b5-1 | $78.48 | +45,767 | 67,496 | +211% | $3.6M |